Web Analytics

3 Latest Announced Rounds

  • $7,500,000
    Seed

    2 Investors

    Software Development
    Nov 21st, 2024
  • $6,000,000
    Series A

    1 Investors

    Transportation, Logistics, Supply Chain and Storage
    Nov 21st, 2024
  • $30,000,000
    Unknown

    1 Investors

    Financial Services
    Nov 21st, 2024
$1,631.41M Raised in 96 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Aelius Biotech

start up
United Kingdom - Newcastle upon Tyne, Tyne and Wear
  • 28/11/2023
  • Unknown
  • $1,578,000

Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.


Related People

Peter ChaterCo Founder

Peter Chater United Kingdom - Newcastle upon Tyne, England

At Aelius Biotech we develop and use in vitro models of the aero-digestive tract to help our collaborators and customers test and develop new formulations, drug delivery systems and functional foods.

We've developed the first in vitro system to model the processes of digestion, mucus permeation and epithelial absorption in a single lab system, and have shown how this can be used as an effective screening/development tool for oral formulations. Send me a message if you want more information.